161110-00-5

161110-00-5 structure

Name: N4-BENZOYL-3'-DEOXYCYTIDINE
Chemical Name: N-[1-[(2R,3R,5S)-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide
CAS Number: 161110-00-5
Molecular Formula: C₁₆H₁₇N₃O₅
Molecular Weight: 331.32
Catalog: Signaling Pathways Cell Cycle/DNA Damage Nucleoside Antimetabolite/Analog
Create Date: 2016-05-16 16:58:40
Modify Date: 2026-06-30 23:57:16
N4-Benzoyl-3’-deoxycytidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

Name	N-[1-[(2R,3R,5S)-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide
Synonyms	N4-Benzoyl-3'-deoxy-D-cytidine N-(1-((2R,3R,5S)-3-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide N4-benzoyl-3'-deoxyribicytidine N-Benzoyl-3'-deoxycytidine N-benzoyl-3'-deoxy-(9CI)Cytidine N4-benzoyl-3'-deoxycytidine N4-Benzoyl-3'-deoxycytidine Cytidine, N-benzoyl-3'-deoxy- (9CI) N4-Benzoyl-3′-deoxycytidine

Description	N4-Benzoyl-3’-deoxycytidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Cell Cycle/DNA Damage >> Nucleoside Antimetabolite/Analog
References	[1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88.